The Roche Cobas Electrochemiluminescent Immunoassy (ECLIS) test measures detectable antibodies (IgG, IgA, and IgM) to the nucleocapsid protein of SARS-CoV-2

We believe in the efficiency of quality. High quality results cost a little more to produce, but pay larger benefits in patient care. Our commitment to quality control and quality assurance has three components that overlap to assure accurate testing results.

Our representatives will assure that your questions or concerns are promptly and courteously handled or channeled to the appropriate technical or professional personnel.

This includes both external CAP proficiency surveys and also an internal quality control program. Coefficients of variation, standard deviations, standards and control monitors are analyzed to assure that the results are reliable.

Multi-speciality, Chemistry, Hematology, and Serology profiles, in addition to single tests, Endocrinology, and Therapeutic Drug Assay, services are available.

to verify that both our own internal and national external standards are met or exceeded. We voluntarily subscribe to the College of American Pathologists inter-laboratory comparison and external proficiency program. All testing personnel in our laboratory participate in the proficiency program.